These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study. Park CH; Suh JH; Yoo HS; Lee JT; Kim DI Clin Nucl Med; 1986 Jul; 11(7):514-7. PubMed ID: 3015472 [TBL] [Abstract][Full Text] [Related]
43. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Lau WY; Lai EC; Leung TW; Yu SC Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922 [TBL] [Abstract][Full Text] [Related]
44. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961 [TBL] [Abstract][Full Text] [Related]
45. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma. Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603 [TBL] [Abstract][Full Text] [Related]
46. Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol. Yoo HS; Suh JH; Lee JT; Kim KW; Kim DI; Kim BS; Choi HJ; Lee KS J Korean Med Sci; 1990 Jun; 5(2):75-83. PubMed ID: 2177607 [TBL] [Abstract][Full Text] [Related]
47. [Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol)]. Kajiya Y; Nakajo M; Kobayashi H; Oyama T; Shinohara S Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):815-21. PubMed ID: 2849622 [No Abstract] [Full Text] [Related]
51. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma. Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134 [TBL] [Abstract][Full Text] [Related]
52. 131I-Labelled-iodized oil for palliative treatment of hepatocellular carcinoma. Borbath I; Lhommel R; Bittich L; Goffette P; Annet L; Van Beers BE; Bonny MA; Pauwels S; Horsmans Y Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):905-10. PubMed ID: 16093866 [TBL] [Abstract][Full Text] [Related]
53. Development of Semiautomated Module for Preparation of Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645 [TBL] [Abstract][Full Text] [Related]
54. Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma. Raoul JL; Duvauferrier R; Bretagne JF; Bourguet P; Heresbach D; Siproudhis L; Gosselin M Scand J Gastroenterol; 1993 Mar; 28(3):217-23. PubMed ID: 7680489 [TBL] [Abstract][Full Text] [Related]
55. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol. Raoul JL; Messner M; Boucher E; Bretagne JF; Campion JP; Boudjema K Br J Surg; 2003 Nov; 90(11):1379-83. PubMed ID: 14598418 [TBL] [Abstract][Full Text] [Related]
56. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases. Liepe K; Kotzerke J; Lambert B J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601 [No Abstract] [Full Text] [Related]
57. [Severe ischemic necrotizing cholangitis after intra-arterial iodine 131-labeled Lipiodol as therapy for hepatocellular carcinoma]. Vergniol J; Dubuc J; Le Bail B; Drouillard J; Couzigou P; De Ledinghen V Gastroenterol Clin Biol; 2004 Apr; 28(4):403-4. PubMed ID: 15146158 [No Abstract] [Full Text] [Related]
58. Hepatocellular carcinoma with skeletal metastasis: management with intraarterial radioactive iodine. Cho YD; Yum HY; Park YH J Belge Radiol; 1989 Aug; 72(4):267-71. PubMed ID: 2551883 [TBL] [Abstract][Full Text] [Related]
59. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma. De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257 [TBL] [Abstract][Full Text] [Related]
60. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol. Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]